Are you or a loved one eligible for compensation?
If you or a loved one were diagnosed with lymphoma after receiving Dupixent injections, you may be eligible to pursue legal action and seek compensation. Complete the confidential form on this page to learn more about the Dupixent lawsuit and whether you may qualify to file.
Recent lawsuits claim that Dupixent may cause or accelerate certain types of lymphoma, including Cutaneous T-Cell Lymphoma (CTCL), mycosis fungoides and other life-threatening medical conditions. Affected patients are now taking legal action against the drug’s manufacturers, alleging they were aware of potential risks and failed to adequately warn patients and doctors.
Patients who received Dupixent injections and were later diagnosed with lymphoma may have legal options worth exploring.
Do you qualify?
If you received Dupixent injections for more than three months and were later diagnosed with CTCL or any of the following cancers, you may be eligible to file a Dupixent lawsuit:
- Cutaneous T-Cell Lymphoma
- Mycosis Fungoides
- Sézary Syndrome
- Lymphomatoid Papulosis
- Anaplastic Large Cell Lymphoma
- Extranodal Natural Killer (NK) T-Cell Lymphoma
- Subcutaneous Panniculitis-Like T-Cell Lymphoma
- Adult T-Cell Leukemia/Lymphoma
- Follicular Helper T-Cell Lymphoma
- Peripheral T-Cell Lymphoma
To determine if you qualify, please complete the confidential form on this page for a free case review..
Fill out the form on this page for more information.
The law firms responsible for the content of this page are: Dolman Law Group Accident Injury Lawyers P.A.; Clearwater, FL; 866-481-5347; dolmanlaw.com and LegaFi Law LLC (an Arizona law firm), 888-4-LegaFi, www.legafi.com.
What is Dupixent, and why is it being linked to CTCL in lawsuits?
Dupixent is a prescription injectable medication used to treat eczema (atopic dermatitis), asthma, chronic obstructive pulmonary disease (COPD) and other inflammatory conditions. While effective for these conditions, recent clinical reports suggest a potential link between Dupixent and the development of lymphoma, including Cutaneous T-Cell Lymphoma, in some patients.
Why are Dupixent lawsuits being filed?
Dupixent lawsuits allege that the manufacturers failed to properly warn patients and healthcare providers about the potential risks of the drug. Plaintiffs claim the company did not update safety information after clinical evidence emerged and did not adequately inform doctors or patients that Dupixent may increase the risk of developing lymphoma.
Types of lymphoma and cancer linked to Dupixent use
Research and clinical reports have suggested a potential link between Dupixent and several types of rare blood and skin cancers. Individuals who have received Dupixent and were later diagnosed with any of the following conditions may qualify to take part in a Dupixent lawsuit:
- Cutaneous T-Cell Lymphoma
- Mycosis Fungoides
- Sézary Syndrome
- Lymphomatoid Papulosis
- Anaplastic Large Cell Lymphoma
- Extranodal Natural Killer T-Cell Lymphoma
- Subcutaneous Panniculitis-Like T-Cell Lymphoma
- Adult T-Cell Leukemia/Lymphoma
- Follicular Helper T-Cell Lymphoma
- Peripheral T-Cell Lymphoma
How to file a Dupixent lawsuit
If you or a loved one were diagnosed with CTCL or another type of lymphoma after using Dupixent for three months or longer, you may be eligible to pursue a Dupixent lawsuit.
To initiate the process, please share your experience using the confidential form on this page. Your information will be reviewed by an experienced legal professional who may contact you to discuss potential next steps and any available legal options you may have.
Fill out the form on this page to see if you qualify for a free case evaluation.
See If You Qualify
Join a Dupixent lawsuit investigation
Filling out this form is quick and easy. It only takes a few minutes to see if you qualify.
After you fill out the form, an attorney(s) or their agent(s) may contact you to discuss your legal rights.
ATTORNEY ADVERTISING
The choice of a lawyer is an important decision and should not be based solely on advertisements.
PAID ATTORNEY ADVERTISEMENT: THIS WEB PAGE IS AN ADVERTISEMENT AND THE PARTICIPATING ATTORNEY(S) ARE INCLUDED BECAUSE THEY PAY AN ADVERTISING FEE. Top Class Actions is not a law firm, lawyer referral service, or prepaid legal services plan. We do not endorse or recommend any third-party claims processing company, lawyer, or law firm who participates in the network. We do not make any representation, and have not made any judgment, as to the qualifications, expertise, or credentials of any participating lawyer or processing group. No representation is made that the quality of the legal services or claims processing to be performed is greater than the quality of legal services or claims processing performed by other lawyers or claims processing group. The information contained herein is not legal advice. Any information you submit to Top Class Actions does not create an attorney-client relationship and may not be protected by attorney-client privilege because Top Class Actions is not a law firm. Instead, your information will be forwarded to an attorney(s) or their agent(s) or a claims processing firm for the purpose of a confidential review and potential representation if you qualify. You will only be contacted by an attorney(s) or their agent(s) in response to your inquiry if your initial information appears to qualify you for representation. If you are not contacted by an attorney(s) or their agent(s) within one week, you should consult another firm since all legal claims are subject to filing deadlines. All photos on this website are stock art and do not depict clients.
